Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 19, 2008 06:23 ET | Source: Topotarget

Interim report - six months ended 30 June 2008

TopoTarget A/S Symbion Fruebjergvej 3 DK 2100 Copenhagen Denmark Tel: +45 39 17 83 92 Fax: +45 39 17 94 92 CVR-nr: 25695771 www.topotarget.com To OMX Nordic Exchange...
August 19, 2008 06:23 ET | Source: Topotarget

Delårsrapport for 1. halvår 2008

TopoTarget A/S Symbion Fruebjergvej 3 2100 København Ø Danmark Tlf: +45 39 17 83 92 Fax: +45 39 17 94 92 CVR-nr: 25695771 www.topotarget.com Til OMX Den Nordiske Børs København Meddelelse...
July 24, 2008 03:32 ET | Source: Topotarget

Fase IV post marketing resultater for Totect® godkendt af FDA

TopoTarget A/S Symbion Fruebjergvej 3 2100 København Ø Danmark Tlf: +45 39 17 83 92 Fax: +45 39 17 94 92 CVR-nr: 25695771 www.topotarget.com Til OMX Den Nordiske Børs...
July 24, 2008 03:32 ET | Source: Topotarget

Phase IV post marketing study results for Totect® accepted by the FDA

TopoTarget A/S Symbion Fruebjergvej 3 DK 2100 Copenhagen Denmark Tel: +45 39 17 83 92 Fax: +45 39 17 94 92 CVR-nr: 25695771 www.topotarget.com To OMX Nordic Exchange...
July 09, 2008 05:42 ET | Source: Topotarget

TopoTarget præsenterer nye kliniske resultater for belinostat på det kommende årsmøde, ESMO, samt på konferencen 7th Biennial Ovarian Cancer Research Symposium

TopoTarget A/S Symbion Fruebjergvej 3 2100 København Ø Danmark Tlf: +45 39 17 83 92 Fax: +45 39 17 94 92 CVR-nr: 25695771 www.topotarget.com TopoTarget præsenterer nye kliniske resultater...
July 09, 2008 05:42 ET | Source: Topotarget

TopoTarget Present New Clinical Results with belinostat at the 33rd ESMO Congress and the 7th Biennial Ovarian Cancer Research Symposium

TopoTarget A/S Symbion Fruebjergvej 3 DK 2100 Cpenhagen Denmark Tel: +45 39 17 83 92 Fax: +45 39 17 94 92 CVR-nr: 25695771 www.topotarget.com TopoTarget Present New Clinical Results with...
June 19, 2008 07:19 ET | Source: Topotarget

TopoTarget har modtaget detaljeret vejledning fra FDA angående dets registreringsstudie med belinostat til behandling af PTCL

TopoTarget A/S Symbion Fruebjergvej 3 2100 København Ø Danmark Tlf: +45 39 17 83 92 Fax: +45 39 17 94 92 CVR-nr: 25695771 www.topotarget.com Til OMX Den Nordiske Børs...
June 19, 2008 07:19 ET | Source: Topotarget

TopoTarget received detailed advice from the FDA concerning its pivotal trial with belinostat in PTCL

TopoTarget A/S Symbion Fruebjergvej 3 DK 2100 Copenhagen Denmark Tel: +45 39 17 83 92 Fax: +45 39 17 94 92 CVR-nr: 25695771 www.topotarget.com To OMX Nordic Exchange...
June 06, 2008 02:07 ET | Source: Topotarget

TopoTarget offentliggør positive data fra et fase II studie med belinostat som enkeltstofbehandling

TopoTarget A/S Symbion Fruebjergvej 3 2100 København Ø Danmark Tlf: +45 39 17 83 92 Fax: +45 39 17 94 92 CVR-nr: 25695771 www.topotarget.com Til OMX Den Nordiske Børs...
June 06, 2008 02:07 ET | Source: Topotarget

TopoTarget announces positive data from a phase II study of belinostat monotherapy

TopoTarget A/S Symbion Fruebjergvej 3 DK 2100 Copenhagen Denmark Tel: +45 39 17 83 92 Fax: +45 39 17 94 92 CVR-nr: 25695771 www.topotarget.com To OMX Nordic Exchange...